Literature DB >> 10437992

Neurocognitive dysfunction in dually-diagnosed patients: a potential roadblock to motivating behavior change.

A W Blume1, J M Davis, K B Schmaling.   

Abstract

Substance abuse has been associated with cognitive dysfunction, such as problems with attention, reasoning, and memory. Certain psychiatric disorders also have been associated with cognitive difficulties, thus placing dually-diagnosed patients at high risk for cognitive impairment that could interfere with successful entry into or completion of therapy. Twenty-two dually-disordered inpatients were administered the Brief Readiness to Change Questionnaire to measure levels of motivation to change substance use, and a neuropsychological test battery that included the Wechsler Adult Intelligence Scale-Revised (WAIS-R), the Halstead Category Test (HCT), and the Wechsler Memory Scale-Revised (WMS-R). Higher general intellectual, executive, and memory functioning were significantly related to greater scores in readiness to change substance abuse in this sample. Cognitive ability may be an important variable to consider in the motivation and treatment of dually-diagnosed patients.

Entities:  

Mesh:

Year:  1999        PMID: 10437992     DOI: 10.1080/02791072.1999.10471732

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  9 in total

Review 1.  Neurocognitive impairment and HIV risk factors: a reciprocal relationship.

Authors:  Pria Anand; Sandra A Springer; Michael M Copenhaver; Frederick L Altice
Journal:  AIDS Behav       Date:  2010-12

2.  Letter to the Editor: A Novel Therapeutic for Opioid Use Disorder Targeting the Cholinergic System.

Authors:  Scott J Moeller; Anissa Abi-Dargham
Journal:  Am J Addict       Date:  2019-06-04

3.  White matter integrity as a link in the association between motivation to abstain and treatment outcome in adolescent substance users.

Authors:  Tammy Chung; Stefan Pajtek; Duncan B Clark
Journal:  Psychol Addict Behav       Date:  2012-02-27

4.  Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change.

Authors:  Marsha E Bates; Anthony P Pawlak; J Scott Tonigan; Jennifer F Buckman
Journal:  Psychol Addict Behav       Date:  2006-09

5.  Lack of motivation for treatment in emergency psychiatry patients.

Authors:  Cornelis L Mulder; Gerrit T Koopmans; Michiel W Hengeveld
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-06       Impact factor: 4.328

6.  A Self-Report Measure to Detect Neurocognitive Impairment among Incarcerated People Living with HIV in Malaysian Context: An Exploratory Factor Analysis.

Authors:  Roman Shrestha; Damian Weikum; Michael Copenhaver; Frederick L Altice
Journal:  Int J Ment Health Addict       Date:  2017-04-03       Impact factor: 3.836

7.  An Exploratory Factor Analysis of a Brief Self-Report Scale to Detect Neurocognitive Impairment Among Participants Enrolled in Methadone Maintenance Therapy.

Authors:  Michael Copenhaver; Roman Shrestha; Jeffrey A Wickersham; Damian Weikum; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2016-01-13

Review 8.  Cognitive Decline and Recovery in Alcohol Abuse.

Authors:  Christina J Perry
Journal:  J Mol Neurosci       Date:  2016-07-27       Impact factor: 3.444

9.  Cognitive profiles in persons with opioid use disorder enrolled in methadone treatment.

Authors:  Victoria Sanborn; John Gunstad; Roman Shrestha; Colleen B Mistler; Michael M Copenhaver
Journal:  Appl Neuropsychol Adult       Date:  2020-05-28       Impact factor: 2.050

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.